`109-MS-301 and 109-MS-302
`
`Thursday, 2"‘ November 2006
`
`DISTRIBUTION I ATTENDEES
`
`BIIB Attendees
`
`awson
`HIIIIIUE Ian ate
`
`Names In BOLD attended this meetin
`
`Page 1 Of 6
`
`Biogen Exhibit 2214
`Coalition v. Biogen
`IPR2015-01993
`
`
`
`
`
`MINUTES
`
`109MS301: Study Start-up Update -E
`
`re urned
`243 CDAs have been sent out, 1
`-
`181 SRQs have been sent out, 75 returned
`-
`about 30 sites have been approved to participate
`-
`Australia:
`-
`EC submission for‘ and‘ pending
`New Zealand:
`o
`EC central submission scheduled for 14 Nov
`
`fiiu_m:
`- Approval received for coordinating site‘
`-
`EC submission on 20 Nov
`
`Action:- to contact Imperial Graphics to get VAS for Belgium by Friday 3 Nov
`
`195 CDAs have been sent out, 1?! relurned
`
`loo
`
`158 SRQs have been sent out, 7 returned
`2 has begun contacting sites for 302 this week
`
`# of sites that will receive approval for 109MS301 protocol version 1
`Worst case scenario: 3 Aus sites, 3 NZ. 6 Belgium
`Recommendation provided to]: use protocol V1 in Belgium for the first regulatory submission
`
`
`
`Brazil Update
`- Move Brazil from 302 to 301
`
`o
`o
`
`BIIB Commercial has identified a potential lead physician
`BIIB requested for
`to begin contacting sites for 301
`
`Actiofl will forwar
`
`list to
`
`email/information for Brazil potential lead site and. will forward Brazil
`
`South Africa 8 am Ireland
`
`South Africa:
`
`-
`
`Potentially out of both 301 and 302, however
`approve the 1996 version of the Declaration o
`
`is looking into regions within S. Africa that will
`elsinki, more info to follow from- next week
`
`Page 2 of 6
`
`
`
`
`
`
`
`Page 3 of 6Page 3 of 6
`
`Page 3 of 6
`
`
`
`ACTION ITEMS
`
`Ongoing
`
`ICF to be modified due to results from EOP2
`mwtin
`
`dT
`
`d—
`
`05 October 2006
`
`_ SITE $_ELEC n_oN
`email‘/inforrnationvfiom
`F will toiward
`razil gotentjal ead site
`to Biazil liivesligatoi list to
`to send! the site number ist
`to provi 9 update on potential sites in
`u h Afflcla
`to discuss sites with!
`_.$.ll9995?‘?£5.?!dd.l1l9f!'¢l‘, $_l?_°f5_ 9
`ICF
`
`to send
`
`301 Sign Offof NA model ICF
`
`301 Sign Off NA model ICF
`
`301 Sign Off of suppleiiieiilal lCFs (Duiiiiiv
`M&_MR9
`301 Sign oft ol supplemental I(Zl~ (Pipedia
`lCF, Canadian Version of Plll)
`301 Sign Off of supplemental ICFS
`aimacoenomic
`
`Rog to confirm date for Health Canada
`B612 SMI Meeting Minutes
`
`Page 4 of 6
`
`
`
`—
`°°'“"'°“*—
`U
`°°"“"°‘“—
`d
`Complete
`d
`
`Pending
`
`Pending
`
`d d
`
`28"” 5°“
`23’ 5°“
`28* Sept
`
`28* Sew
`
`28”‘ Sept
`
`Pending
`
`25" Oct
`
`d
`o
`Pendi
`--
`2""~°vE—
`WV -E—
`O
`
`submission date for 301
`302 Sign Off of International model ICF
`
`302 Sign Offof NA model /C/'
`
`302 Sign Off of supplemental ICF (disease
`progression / rolapso)
`
`302 Sign Olfol supplerrrerital ICF (Dummy -
`Ml~‘cI/MRI)
`30') Sign on of supplemental l()l- (P/pedra
`ICF, Ca/iadia/i Version of PH!)
`302 Sign Off of supplemental ICF (PHI)
`
`302 Sign Off of supplemental ICF
`(plmrrnacogennmic)
`
`to follow ug with MRI center on MRI ICF I
`F
`
`F in contact Impenal Graphics to get VAS
`or t3,9|£1i9m_I2y Friday 9. Nov 7
`to distr bute 3o1v'i Gdidéitnes and 302
`F5 and schedule review meetings
`to follow up
`on CRF Completion
`uideline date
`
`Questionnaires
`
`KKl')"td dévein réieptirme reiahse
`questionnaire for 301 and 302.. KD and
`the team to consider whether to capture in
`
`up Sept
`
`9“ Nov
`
`Page 5 of 6
`
`
`
`
`
`
`
`Page 6 of 6Page 6 of 6
`
`Page 6 of 6
`
`